Articles

CFO Denis Coleman sees deal-making confidence building, while fixed income and equities businesses gain traction.

CVS Health shares climbed as the drug-store chain set 2024 revenue guidance that tops analyst expectations and announced a revamp of its prescription-drug pricing model.

"I’m a tradesman, and we pay for our tools, vehicles and years of training while earning zip."

The media giant's board would benefit from the addition of Peltz, Ancora contends, after an "extended period of absentminded governance, ineffective succession planning, polarizing actions and sustained value destruction."

Federal antitrust enforcers are investigating Exxon Mobil's planned deal to acquire Pioneer Natural Resources for $60 billion

Shares of Amex were selling off Tuesday after the credit-card giant's chief executive hinted at some weakness in October, though he said trends improved in November.

An exchange-traded product that allows investors to place massively leveraged bets on the S&P 500 launched on Tuesday, according to a news release from the sponsor, Bank of Montreal.

Investors and traders flocked back into the safety of U.S. government debt on Tuesday, causing long-term yields to drop in a manner that suggests rising worries about the risk of a faster-than-expected economic slowdown.

You might think you’re sharing lessons about the value of investing, but you need to focus on basics instead.

P&G expects to book more than $2 billion in charges for a limited restructuring and an impairment relating to Gillette, which it acquired in 2005.

Designer Brands Inc.'s stock slid 34% Tuesday, after the parent to footwear brands including DSW, Keds, Lucky Brand and Vince Camuto posted weaker-than-expected third-quarter earnings and cut its guidance.

Greg Tuorto explains how smaller companies can use a narrow focus to make a lot of money for investors.